DUBLIN--(BUSINESS WIRE)--The "Global Blood Group Typing Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The blood group typing market will register a CAGR of almost 10% by 2023.
In recent years, the increasing prevalence of chronic diseases such as diabetes and cancer among individuals is leading to a rising demand for early diagnosis for better patient care.
Blood group testing is necessary for cancer patients, as the disease may require blood transfusion for treatment. Blood products such as platelets used for treating cancer patients have a shorter shelf-life, which increases the demand for blood products. The increase in the prevalence of chronic diseases, coupled with the demand for early diagnosis through blood group typing, has significantly led to the growth of the market.
Rise in donation rates owning to increase in awareness
There has been an increase in the blood donation rate due to the rising importance and awareness of blood donation. Therefore, the demand for blood group typing products such as instruments, consumables, and reagents among end-users such as hospitals, clinics, and blood banks is increasing.
Risks associated with blood transfusion
Blood transfusions involve the risk of complications during or post transfusion. Some of the risks and complications of blood transfusion include acute immune hemolytic reaction wherein the immune system attacks the transfused red blood cells because the donor blood type is not a good match. Thus, the complications and risks arising as a result of blood transfusion are restricting the growth of the global blood group typing market.
Competitive Landscape
The global blood group typing market is moderately concentrated and as the market is in its growth phase, the competition among companies is intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.
Key Players
- Agena Bioscience
- Bio-Rad Laboratories
- Danaher
- Merck KGaA
- Ortho Clinical Diagnostics
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Comparison by product
- Consumables - Market size and forecast 2018-2023
- Instruments - Market size and forecast 2018-2023
- Software - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
- Technological advances focusing on advanced techniques and automated systems
- Increasing government support pertaining to blood safety
- Growing demand for blood transfusions and blood group typing
PART 11: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 12: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Agena Bioscience
- Bio-Rad Laboratories
- Danaher
- Merck KGaA
- Ortho Clinical Diagnostics
For more information about this report visit https://www.researchandmarkets.com/research/4l43bd/the_worldwide?w=4
